Anti-OSMR/ IL-31R-beta/ IL-31RBB monoclonal antibody

Anti-OSMR/ IL-31R-beta/ IL-31RBB antibody for FACS & in-vivo assay

Target products collectionGo to OSMR/OSMR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T78567-Ab-1/ GM-Tg-hg-T78567-Ab-2Anti-Human OSMR monoclonal antibodyHuman
GM-Tg-rg-T78567-Ab-1/ GM-Tg-rg-T78567-Ab-2Anti-Rat OSMR monoclonal antibodyRat
GM-Tg-mg-T78567-Ab-1/ GM-Tg-mg-T78567-Ab-2Anti-Mouse OSMR monoclonal antibodyMouse
GM-Tg-cynog-T78567-Ab-1/ GM-Tg-cynog-T78567-Ab-2Anti-Cynomolgus/ Rhesus macaque OSMR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T78567-Ab-1/ GM-Tg-felg-T78567-Ab-2Anti-Feline OSMR monoclonal antibodyFeline
GM-Tg-cang-T78567-Ab-1/ GM-Tg-cang-T78567-Ab-2Anti-Canine OSMR monoclonal antibodyCanine
GM-Tg-bovg-T78567-Ab-1/ GM-Tg-bovg-T78567-Ab-2Anti-Bovine OSMR monoclonal antibodyBovine
GM-Tg-equg-T78567-Ab-1/ GM-Tg-equg-T78567-Ab-2Anti-Equine OSMR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T78567-Ab-1/ GM-Tg-hg-T78567-Ab-2; GM-Tg-rg-T78567-Ab-1/ GM-Tg-rg-T78567-Ab-2;
GM-Tg-mg-T78567-Ab-1/ GM-Tg-mg-T78567-Ab-2; GM-Tg-cynog-T78567-Ab-1/ GM-Tg-cynog-T78567-Ab-2;
GM-Tg-felg-T78567-Ab-1/ GM-Tg-felg-T78567-Ab-2; GM-Tg-cang-T78567-Ab-1/ GM-Tg-cang-T78567-Ab-2;
GM-Tg-bovg-T78567-Ab-1/ GM-Tg-bovg-T78567-Ab-2; GM-Tg-equg-T78567-Ab-1/ GM-Tg-equg-T78567-Ab-2
Products NameAnti-OSMR monoclonal antibody
Formatmab
Target NameOSMR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OSMR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-623Pre-Made Vixarelimab biosimilar, Whole mAb, Anti-OSMR Antibody: Anti-IL-31R-beta/IL-31RB/OSMRB/OSMRbeta/PLCA1 therapeutic antibody
    Target AntigenProducts DevelopingMulti-species OSMR/ IL-31R-beta/ IL-31RBB VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-T78567-Ag-1oncostatin M receptor (OSMR) protein


    Target information

    Target IDGM-T78567
    Target NameOSMR
    Gene ID9180,18414,310132,693569,489223,101096447,514720,100066819
    Gene Symbol and SynonymsIL-31R-beta,IL-31RB,OSMR,OSMRB,OSMRbeta,PLCA1
    Uniprot AccessionQ99650,Q65Z14
    Uniprot Entry NameOSMR_HUMAN,OSMR_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index, Cytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000145623
    Target ClassificationN/A

    The target: OSMR, gene name: OSMR, also named as IL-31R-beta, IL-31RBB, PLCA1, OSMR. This gene encodes a member of the type I cytokine receptor family. The encoded protein heterodimerizes with interleukin 6 signal transducer to form the type II oncostatin M receptor and with interleukin 31 receptor A to form the interleukin 31 receptor, and thus transduces oncostatin M and interleukin 31 induced signaling events. Mutations in this gene have been associated with familial primary localized cutaneous amyloidosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.